(Hypertension. 1998;31:421.)
© 1998 American Heart Association, Inc.
Scientific Contributions |
Calcium Mobilization Contributes to Pressure-Mediated Afferent Arteriolar Vasoconstriction
Department of Physiology (E.W.I., A.K.C., V.M., J.D.I,), Tulane University School of Medicine, New Orleans, Louisiana 70112.
Correspondence to Edward W. Inscho, Department of Physiology, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112. E-mail einscho{at}mailhost.tcs.tulane.edu
Preglomerular responses to vasoactive agonists utilize calcium released from intracellular stores and activation of calcium influx pathways to elicit vasoconstriction. The current study was performed to determine the role of calcium release from intracellular stores on the afferent arteriolar response to increases in perfusion pressure. Experiments were performed, in vitro, using the blood perfused, juxtamedullary nephron technique combined with videomicroscopy. The response of afferent arterioles to 30 mm Hg increases in perfusion pressure was determined before and after depletion of intracellular calcium pools with a 10-minute preincubation with 1 µmol/L thapsigargin or 100 µmol/L cyclopiazonic acid. Afferent arteriolar diameter averaged 20.2±1.0 µm (n = 19) at a control perfusion pressure of 100 mm Hg. Increasing perfusion pressure to 130 and 160 mm Hg reduced afferent caliber by 10.7±1.0% (P<.05 versus con) and by 24.7±1.6% (P<.05 versus diameter at 130 mm Hg); respectively. Thapsigargin significantly increased afferent diameter by 21±2% (n = 6) at 100 mm Hg and prevented pressure-induced autoregulatory responses. Afferent diameter averaged 24.3±1.7, 24.5±1.8 and 24.3±1.8µm at perfusion pressures of 100, 130 and 160 mm Hg; respectively. Cyclopiazonic acid treatment also inhibited autoregulatory behavior but did not alter resting vessel diameter. Afferent arteriolar diameter (n = 6) averaged 21.4±1.9µm at 100 mm Hg and 20.9±2.1 and 20.5±2.2µm at 130 and 160 mm Hg; respectively. Additional studies were performed to assess the role of phospholipase C activity in pressure-mediated autoregulatory behavior of afferent arterioles. Step increases in perfusion pressure decreased afferent diameter by 10.7±3.8 and 21.7±4.1%; respectively. Administration of the phospholipase C inhibitor, U-73122, (5 µmoles/L) did not significantly alter baseline diameter but did attenuate the pressure-mediated vasoconstrictor response. Increasing perfusion pressure to 130 and 160 mm Hg reduced afferent diameter by only 6.5±1.5 and 10.0±2.0%; respectively. These data demonstrate that interruption of calcium mobilization with thapsigargin, cyclopiazonic acid, or phospholipase C inhibition markedly attenuates pressure-mediated afferent arteriolar vasoconstriction and suggests that autoregulatory adjustments in afferent arteriolar diameter involve calcium release from inositoltrisphosphate (IP3)-sensitive intracellular stores.
Key Words: calcium mobilization • thapsigargin • cyclopiazonic acid • autoregulation • phospholipase C • U-73122 • microcirculation • renal
Abbreviations: TGF = tubuloglomerular feedback • IP3 = inositoltrisphosphate
This article has been cited by other articles:
 |
|
 |
|
  E. W. Inscho, A. K. Cook, R. C. Webb, and L.-M. Jin Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter Am J Physiol Renal Physiol, March 1, 2009; 296(3): F590 - F597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kleinstreuer, T. David, M. J. Plank, and Z. Endre Dynamic myogenic autoregulation in the rat kidney: a whole-organ model Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1453 - F1464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Thai, S. K. Fellner, and W. J. Arendshorst ADP-ribosyl cyclase and ryanodine receptor activity contribute to basal renal vasomotor tone and agonist-induced renal vasoconstriction in vivo Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1107 - F1114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhao, A. K. Cook, M. Field, B. Edwards, S. Zhang, Z. Zhang, J. S. Pollock, J. D. Imig, and E. W. Inscho Impaired Ca2+ Signaling Attenuates P2X Receptor-Mediated Vasoconstriction of Afferent Arterioles in Angiotensin II Hypertension Hypertension, September 1, 2005; 46(3): 562 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Pollock, J. M. Jenkins, A. K. Cook, J. D. Imig, and E. W. Inscho L-type calcium channels in the renal microcirculatory response to endothelin Am J Physiol Renal Physiol, April 1, 2005; 288(4): F771 - F777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Fallet, H. Ikenaga, J. P. Bast, and P. K. Carmines Relative contributions of Ca2+ mobilization and influx in renal arteriolar contractile responses to arginine vasopressin Am J Physiol Renal Physiol, March 1, 2005; 288(3): F545 - F551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Smeda Stroke Development in Stroke-Prone Spontaneously Hypertensive Rats Alters the Ability of Cerebrovascular Muscle to Utilize Internal Ca2+ to Elicit Constriction Stroke, June 1, 2003; 34(6): 1491 - 1496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hirota, A. Ichihara, Y. Koura, M. Hayashi, and T. Saruta Phospholipase D Contributes to Transmural Pressure Control of Prorenin Processing in Juxtaglomerular Cell Hypertension, February 1, 2002; 39(2): 363 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Hill, H. Zou, S. J. Potocnik, G. A. Meininger, and M. J. Davis Signal Transduction in Smooth Muscle: Invited Review: Arteriolar smooth muscle mechanotransduction: Ca2+ signaling pathways underlying myogenic reactivity J Appl Physiol, August 1, 2001; 91(2): 973 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Schroeder, J. D. Imig, E. A. LeBlanc, B. T. Pham, D. M. Pollock, and E. W. Inscho Endothelin-Mediated Calcium Signaling in Preglomerular Smooth Muscle Cells Hypertension, January 1, 2000; 35(1): 280 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ichihara, H. Suzuki, Y. Miyashita, M. Naitoh, M. Hayashi, and T. Saruta Transmural pressure inhibits prorenin processing in juxtaglomerular cell Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1999; 277(1): R220 - R228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Davis and M. A. Hill Signaling Mechanisms Underlying the Vascular Myogenic Response Physiol Rev, April 1, 1999; 79(2): 387 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. W. Inscho, A. C. Schroeder, P. C. Deichmann, and J. D. Imig ATP-mediated Ca2+ signaling in preglomerular smooth muscle cells Am J Physiol Renal Physiol, March 1, 1999; 276(3): F450 - F456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. W. Inscho and A. K. Cook P2 receptor-mediated afferent arteriolar vasoconstriction during calcium blockade Am J Physiol Renal Physiol, February 1, 2002; 282(2): F245 - F255. [Abstract] [Full Text] [PDF]
|
|